Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

BlackBerry’s Price Surge Hints at Good News on the Horizon

By Larry Ramer, InvestorPlace Contributor

BB stock is likely to be boosted by some excellent news on one or two fronts, making the shares very appealing at this point.

With the Infrastructure Bill Likely To Pass, ChargePoint Stock Is Undervalued

By Larry Ramer, InvestorPlace Contributor

Investors are underestimating the chances of two Congressional bills passing, and they're overlooking ChargePoint's brand power. CHPT stock is a buy.

Comparing ContextLogic in 2021 With Snap in 2018

By Larry Ramer, InvestorPlace Contributor

Like SNAP stock in 2018, poor user metrics are driving down WISH stock now. And like Snap then, the fundamentals of ContextLogic are strong.

GE Stock Looks Like a Good Buy Here Following Impressive Q2 Results

By Larry Ramer, InvestorPlace Contributor

With GE reporting strong Q2 results and the conglomerate poised to benefit from multiple catalysts, investors should buy GE stock.

Ocugen Stock Still Looks Poised to Tumble

By Larry Ramer, InvestorPlace Contributor

Ocugen's apparent failure to prepare a U.S. trial for Covaxin, which will likely be necessary for FDA approval, bodes badly for OCGN stock.

Load More